Ethnic differences in urine concentration: Possible relationship to blood pressure

Clinical Journal of the American Society of Nephrology

Volumn 2, Issue 2, 2007, Pages 304-312

  Bankir, Lise ^a,b   Perucca, Julie ^a,b   Weinberger, Myron H ^c  

^a INSERM   (France)

^b CENTRE DE RECHERCHE DES CORDELIERS   (France)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD PRESSURE; CAUCASIAN; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; RETROSPECTIVE STUDY; URINE;

ADOLESCENT; ADULT; AFRICAN AMERICANS; BLOOD PRESSURE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; RETROSPECTIVE STUDIES; URINE;

EID: 34548843043     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03401006     Document Type: Article

References (58)

1. Luft FC, Grim CE, Higgins JT Jr, Weinberger MH: Differences in response to sodium administration in normotensive white and black subjects. J Lab Clin Med 90: 555-562, 1977
2. Harshfield GA, Alpert BS, Pulliam DA, Willey ES, Somes GW, Stapelton FB: Sodium excretion and racial differences in ambulatory blood pressure patterns. Hypertension 18: 813-818, 1991
3. Luft FC, Grim CE, Fineberg N, Weinberger MC: Effects of volume expansion and contraction in normotensive whites, blacks, and subjects of different ages. Circulation 59: 643-650, 1979
4. Dustan HP, Curtis JJ, Luke RG, Rostand SG: Systemic hypertension and the kidney in black patients. Am J Cardiol 60: 73I-77I, 1987
5. Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS: Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 8: II127-II134, 1986
6. Luft FC, Miller JZ, Grim CE, Fineberg NS, Christian JC, Daugherty SA, Weinberger MH: Salt sensitivity and resistance of blood pressure. Age and race as factors in physiological responses. Hypertension 17: I102-I108, 1991
7. Zhang X, Hense H-W, Riegger AJ, Schunkert H: Association of arginine vasopressin and arterial blood pressure in a population-based sample. J Hypertens 17: 319-324, 1999
8. Cowley AW, Skelton MM, Velasquez MT: Sex differences in the endocrine predictors of essential hypertension. Vasopressin versus renin. Hypertension 7: 1151-1160, 1985
9. Crofton JT, Share L, Shade RE, Allen C, Tarnowski D: Vasopressin in the rat with spontaneous hypertension. Am J Physiol 235: H361-H366, 1978
10. Matsuguchi H, Schmid PG, Van Orden D, Mark AL: Does vasopressin contribute to salt-induced hypertension in the Dahl strain? Hypertension 3: 174-181, 1981
11. Thibonnier M, Kilani A, Rahman M, Pilumeli DiBlasi T, Warner K, Smith MC, Leenhardt AF, Brouard R: Effects of the nonpeptide V1 vasopressin receptor antagonist SR49059 in hypertensive patients. Hypertension 34: 1293-1300, 1999
12. Schafer JA: Abnormal regulation of ENaC: Syndromes of salt retention and salt wasting by the collecting duct. Am J Physiol Renal Physiol 283: F221-F235, 2002
13. Bankir L, Fernandes S, Bardoux P, Bouby N, Bichet DG: Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans. J Am Soc Nephrol 16: 1920-1928, 2005
14. Choukroun G, Schmitt F, Martinez F, Drueke TB, Bankir L: Low urine flow reduces the capacity to excrete a sodium load in humans. Am J Physiol 273: R1726-R1733, 1997
15. Nicco C, Wittner M, DiStefano A, Jounier S, Bankir L, Bouby N: Chronic exposure to vasopressin upregulates ENaC and sodium transport in the rat renal collecting duct and lung. Hypertension 38: 1143-1149, 2001
16. Fernandes S, Bruneval P, Hagege A, Heudes D, Ghostine S, Bouby N: Chronic V2 vasopressin receptor stimulation increases basal blood pressure and exacerbates deoxycorticosterone acetate-salt hypertension. Endocrinology 143: 2759-2766, 2002
17. Lifton RP, Gharavi AG, Geller DS: Molecular mechanisms of human hypertension. Cell 104: 545-556, 2001
18. Bankir L, Bardoux P, Mayaudon H, Dupuy O, Bauduceau B: Too low urinary flow rate during the day: New factor possibly involved in hypertension and in the lack of nocturnal dipping [in French]. Arch Mal Coeur Vaiss 95: 751-754, 2002
19. Bankir L, Sellin F, Maillard M, Chiolero A, Burnier M: Influence of moderate body weight excess on the nyctohemeral pattern of blood pressure, renal function and sodium and water excretion in patients with essential hypertension [in French]. Arch Mal Coeur Vaiss 97: 777-781, 2004
20. Fujii T, Uzu T, Nishimura M, Takeji M, Kuroda S, Nakamura S, Inenaga T, Kimura G: Circadian rhythm of natriuresis is disturbed in nondipper type of essential hypertension. Am J Kidney Dis 33: 29-35, 1999
21. Bankir L, Bochud M, Maillard M, Bovet P, Shamlaye C, Burnier M: Impaired blood pressure dipping at night is associated with a deficit in sodium excretion during daytime due to a marked excess in reabsorption selectively in the distal nephron [Abstract]. J Am Soc Nephrol 17: 446A, 2006
22. Bakris G, Bursztyn M, Gavras I, Bresnahan M, Gavras H: Role of vasopressin in essential hypertension: Racial differences. J Hypertens 15: 545-550, 1997
23. Bursztyn M, Bresnahan M, Gavras I, Gavras H: Pressor hormones in elderly hypertensive persons. Racial differences. Hypertension 15: I88-I92, 1990
24. Crofton JT, Dustan H, Share L, Brooks DP: Vasopressin secretion in normotensive black and white men and women on normal and low sodium diets. J Endocrinol 108: 191-199, 1986
25. Perucca J, Bouby N, Valeix P, Bankir L: Sex difference in urine concentration across differing ages, sodium intake and level of kidney disease. Am J Physiol Regulatory Integrative Physiol September 21, 2006 [epub ahead of print]
26. Grim CE, Luft FC, Miller JZ, Meneely GR, Battarbee HD, Hames CG, Dahl LK: Racial differences in blood pressure in Evans County, Georgia: Relationship to sodium and potassium intake and plasma renin activity. J Chronic Dis 33: 87-94, 1980
27. Pratt JH, Ambrosius WT, Agarwal R, Eckert GJ, Newman S: Racial difference in the activity of the amiloride-sensitive epithelial sodium channel. Hypertension 40: 903-908, 2002
28. Zerbe RL, Miller JZ, Robertson GL: The reproducibility and heritability of individual differences in osmoregulatory function in nonnal human subjects. J Lab Clin Med 117: 51-59, 1991
29. Namnum P, Insogna K, Baggish D, Hayslett JP: Evidence for bidirectional net movement of creatinine in the rat kidney. Am J Physiol Renal Physiol 244: F719-F723,1983
30. Bankir L, Saha C, Pratt H: Do blacks have a better ability to conserve water than whites? Possible consequences on blood pressure [Abstract]. Hypertension 42: 439, 2003
31. Intersalt Cooperative Research Group: Intersalt: An international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ 297: 319-328, 1988
32. Young JH, Chang YP, Kim JD, Chretien JP, Klag MJ, Levine MA, Ruff CB, Wang NY, Chakravari A: Differential susceptibility to hypertension is due to selection during the out-of-Aftica expansion. PLoS Genet 1: e82, 2005
33. Bouby N, Bachmann S, Bichet D, Bankir L: Effect of water intake on the progression of chronic renal failure in the 5/6 nephrectomized rat. Am J Physiol Renal Physiol 258: F973-F979, 1990
34. Somova L, Mufunda J: Ethnic differences of renin-sodium profile and renal prostaglandins in the pathogenesis of systemic arterial hypertension. Cent Aft J Med 42: 170-175, 1996
35. Warren SE, O'Connor DT: Does a renal vasodilator system mediate racial differences in essential hypertension? Am J Med 69: 425-429, 1980
36. Perucca J, Bankir L: Beneficial effects of potassium on blood pressure: A novel mechanism linked to the distinctive circadian rhythm of urinary potassium excretion [Abstract]. FASEB J 20: A1445, 2006
37. Bakris, GL, Kusmirek SL, Smith AC, Gavras I, Gavras H: Calcium antagonism abolishes the antipressor action of vasopressin (V1) receptor antagonism. Am J Hypertens 10: 1153-1158, 1997
38. Montani JP, Wang JL, Tempini A, Van Vliet BN: Chronic infusion of a V2-vasopressin agonist results in sustained hypertension in rats [Abstract]. FASEB J 14: A675, 2000
39. Lieberthal W, Vasilevsky ML, Valari CR, Levinsky NG: Interactions between ADH and prostaglandins in isolated erythrocyte-perfused rat kidney. Am J Physiol 252: F331-F337, 1987
40. Ecelbarger CA, Kim GH, Terris J, Masilamani S, Mitchell C, Reyes I, Verbalis JG, Knepper MA: Vasopressin-mediated regulation of epithelial sodium channel abundance in rat kidney. Am J Physiol Renal Physiol 279: F46-F53, 2000
41. Nicco C, Bankir L, Bouby N: Effect of salt and water intake on epithelial sodium channel mRNA abundance in the kidney of salt-sensitive Sabra rats. Clin Exp Pharmacol Physiol 30: 963-965, 2003
42. Yagil C, Ben-Ishay D, Yagil Y: Disparate expression of the AVP gene in Sabra hypertension-prone and hypertension-resistant rats. Am J Physiol 271: F806-F813, 1996
43. Pratt JH: A central role for ENaC in the development of hypertension. J Am Soc Nephrol 16: 3154-3159, 2005
44. Saha C, Eckert GJ, Ambrosius WT, Chun TY, Wagner MA, Zhao Q, Pratt JH: Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension. Hypertension 46: 481-487, 2005
45. Toto-Moukouo JA, Safar ME: Increased pulse pressure and carotid vascular resistance in normotensive black African subjects. J Hum Hypertens 4: 247-251, 1990
46. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D: Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart study. Circulation 100: 354-360, 1999
47. Weinberger MH, Fineberg NS, Fineberg SE, Weinberger M: Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension 37: 429-432, 2001
48. Vaccarino V, Berger AK, Abramson J, Black HR, Setaro JF, Davey JA, Krumholz HM: Pulse pressure and risk of cardiovascular events in the systolic hypertension in the elderly program. Am J Cardiol 88: 980-986, 2001
49. Safar ME: Epidemiological aspects of pulse pressure and arterial stiffness. J Hypertens Suppl 17: S37-S40, 1999
50. Stachenfeld NS, Splenser AE, Calzone WL, Taylor MP, Keefe DL: Sex differences in osmotic regulation of AVP and renal sodium handling. J Appl Physiol 91: 1893-1901, 2001
51. Sellin F, Chiolero A, Burnier M, Bankir L: Effect of salt on pulse pressure in normotensive and hypertensive men [Abstract]. Hypertension 42: 446-447, 2003
52. Bankir L, Sellin F, Chiolero A, Burnier M: A reduced nocturnal dipping in blood pressure in patients with moderate essential hypertension is associated with a disturbed diurnal/nocturnal pattern of water and sodium excretion [Abstract]. J Am Soc Nephrol 14: 20A-21A, 2003
53. Sachdeva A, Weder AB: Nocturnal sodium excretion, blood pressure dipping, and sodium sensitivity. Hypertension 48: 527-533, 2006
54. Gretler DD, Fumo MT, Nelson KS, Murphy MB: Ethnic differences in circadian hemodynamic profile. Am J Hypertens 7: 7-14, 1994
55. Hyman DJ, Ogbonnaya K, Taylor AA, Ho K, Pavlik VN: Ethnic differences in nocturnal blood pressure decline in treated hypertensives. Am J Hypertens 13: 884-891, 2000
56. Agyemang C, Bhopal R, Bruijnzeels M, Redekop WK: Does nocturnal blood pressure fall in people of African and South Asian descent differ from that in European white populations? A systematic review and meta-analysis. J Hypertens 23: 913-920, 2005
57. Serradeil-Le-Gal C, Lacour C, Valette G, Garcia G, Foulon L, Galindo G, Bankir L, Pouzet B, Guillon G, Barberis C, Chicot D, Jard S, Vilain P, Garcia C, Marty E, Raufaste D, Brossard G, Nisato D, Maffrand JP, Le-Fur G: Characterization of SR 121463A, a highly potent and selective orally active vasopressin V2 receptor antagonist. J Clin Invest 98: 2729-2738, 1996
58. Verbalis JG: Vasopressin V2 receptor antagonists. J Mol Endocrinol 29: 1-9, 2002